Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-10-16

Clinical Trial Update: Mitigation of Emergence Agitation Through Implementation of Masimo Bridge Therapy [NA]

View source ↗

Summary

A clinical trial evaluating Masimo Bridge Therapy to mitigate emergence agitation has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Washington | Conditions: Emergence Delirium, Agitation, Emergence | NA | Status: WITHDRAWN